Wnt2 as a new therapeutic target in malignant pleural mesothelioma

International Journal of Cancer

Volumn 117, Issue 2, 2005, Pages 326-332

  Mazieres, Julien ^a,b   You, Liang ^a   He, Biao ^a   Xu, Zhidong ^a   Twogood, Sarah ^a   Lee, Amie Y ^a   Reguart, Noemi ^a   Batra, Sonny ^a   Mikami, Iwao ^a   Jablons, David M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c Cancer Center   (United States)

Author keywords

Alimta; Apoptosis; Mesothelioma; Monoclonal antibody; Wnt

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; GLYCOPROTEIN; MONOCLONAL ANTIBODY; PEMETREXED; SMALL INTERFERING RNA; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; WNT PROTEIN; WNT2 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMOSOME 7Q; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; MESOTHELIOMA; PLEURA MESOTHELIOMA; PLEURA TUMOR; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION PROFILING; HUMANS; MESOTHELIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLEURAL NEOPLASMS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 25444496522     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21160     Document Type: Article

References (34)

1. Thatcher N. Second Heidelberg thoracic oncology symposium on the diagnosis and treatment of pleural mesothelioma: introduction. Lung Cancer 2004;45(Suppl 1):S1-2.
2. Kindler HL. Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma. Lung Cancer 2004;45(Suppl 1):S125-7.
3. Bard M, Ruffle P. Malignant mesothelioma: medical oncology-standards, new trends, trials, the French experience. Lung Cancer 2004; 45(Suppl 1):S129-31.
4. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-51.
5. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003;129:199-221.
6. Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 2000;11:273-82.
7. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982;31:99-109.
8. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-20.
9. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275:1787-90.
10. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275:1784-7.
11. Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, Carson DA. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogens 2002;21:6598-605.
12. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002;1:279-88.
13. Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, Kipps TJ, Corr M, Carson DA. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 3118-23.
14. Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003;63:4547-51.
15. Abutaily AS, Collins JE, Roche WR. Cadherins, catenins and APC in pleural malignant mesothelioma. J Pathol 2003;201:355-62.
16. He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons DM. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004;6:7-14.
17. You L, He B, Uematsu K, Xu Z, Mazieres J, Lee A, McCormick F, Jablons DM. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Cancer Res 2004;64:3474-8.
18. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004;23:6672-6.
19. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, Jablons DM. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer celts. Oncogene 2004;23:6170-4.
20. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002;26:199-213.
21. Hanauske AR. The role of Alimta in the treatment of malignant pleural mesothelioma: an overview of preclinical and clinical trials. Lung Cancer 2004;45(Suppl 1):S121-4.
22. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffle P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44.
23. Katoh M. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol 2001;19:1003-7.
24. Yoshida MC, Wada M, Satoh H, Yoshida T, Sakamoto H, Miyagawa K, Yokota J, Koda T, Kakinuma M, Sugimura T. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc Natl Acad Sci USA 1988;85: 4861-4.
25. Roelink H, Wagenaar E, Nusse R. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Oncogene 1992;7:487-92.
26. Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998;23:307-16.
27. Katoh M, Kirikoshi H, Terasaki H, Shiokawa K. WNT2B2 mRNA, up-regulated in primary gastric cancer, is a positive regulator of the WNT- beta-catenin-TCF signaling pathway. Biochem Biophys Res Commun 2001;289:1093-8.
28. Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D, Wolloch Y, Tronick SR, Gazit A, Yaniv A. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 1996;12: 153-8.
29. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T. Expression of Wnt ligands and frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 2002;55:220-6.
30. Katoh M. Differential regulation of WNT2 and WNT2B expression in human cancer. Int J Mol Med 2001;8:657-60.
31. Pham K, Milovanovic T, Barr RJ, Truong T, Holcombe RF. Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopatholosical features. Mol Pathol 2003;56: 280-5.
32. Pass HI, Vogelzang N, Hahn S, Carbone M. Malignant pleural mesothelioma. Curr Probl Cancer 2004;28:93-174.
33. Gazdar AF, Carbone M. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 2003;5:177-81.
34. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M. Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 2004;318: 1-9.